Trial intelligence / Profile preview

Pediatric tigecycline versus ceftriaxone regimen for complicated intra-abdominal infection

2008-005166-31Phase 3Completed

Sponsor
Pfizer
Start
Apr 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tigecycline, ceftriaxone, metronidazole in Intra-abdominal infection (IAI), sponsored by Pfizer. Started Apr 2009; status: completed.

02

Drugs

tigecyclineceftriaxonemetronidazole
03

Conditions

Intra-abdominal infection (IAI)

Beyond the preview

Go deeper on 2008-005166-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005166-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call